Optodynamic simulation of β-adrenergic receptor signalling

Nature Communications

Volumn 6, Issue , 2015, Pages

  Siuda, Edward R ^a   McCall, Jordan G ^a   Al Hasani, Ream ^a   Shin, Gunchul ^b   Park, Sung Il ^b   Schmidt, Martin J ^a   Anderson, Sonya L ^a   Planer, William J ^a   Rogers, John A ^b,c   Bruchas, Michael R ^a,d  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b United States of America   (United States)

^c UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^d WASHINGTON UNIVERSITY IN ST LOUIS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; CYCLIC AMP; G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; RETINA S ANTIGEN; RHODOPSIN; BETA ADRENERGIC RECEPTOR KINASE;

BRAIN; CELLS AND CELL COMPONENTS; ENZYME ACTIVITY; GENE EXPRESSION; SIMULATION;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; BIOSYNTHESIS; BRAIN REGION; CONTROLLED STUDY; DESENSITIZATION; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTERNALIZATION; MALE; MOUSE; NERVE CELL STIMULATION; NONHUMAN; OPTICAL ROTATION; OPTODYNAMIC SIMULATION; OPTOGENETICS; PHOTOACTIVATION; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SIMULATION; ANIMAL; C57BL MOUSE; ENZYMOLOGY; HEK293 CELL LINE; METABOLISM;

ANIMALIA;

ANIMALS; ANXIETY; BETA-ADRENERGIC RECEPTOR KINASES; CYCLIC AMP; HEK293 CELLS; HUMANS; MALE; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASES; OPTOGENETICS;

EID: 84942770503     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms9480     Document Type: Article

References (58)

1. Boyden, E. S., Zhang, F., Bamberg, E., Nagel, G. & Deisseroth, K. Millisecondtimescale, genetically targeted optical control of neural activity. Nat. Neurosci. 8, 1263-1268 (2005).
2. Li, X. et al. Fast noninvasive activation and inhibition of neural and network activity by vertebrate rhodopsin and green algae channelrhodopsin. Proc. Natl Acad. Sci. USA 102, 17816-17821 (2005).
3. Ishizuka, T., Kakuda, M., Araki, R. & Yawo, H. Kinetic evaluation of photosensitivity in genetically engineered neurons expressing green algae lightgated channels. Neurosci. Res. 54, 85-94 (2006).
4. Zhang, F., Aravanis, A. M., Adamantidis, A., de Lecea, L. & Deisseroth, K. Circuit-breakers: optical technologies for probing neural signals and systems. Nat. Rev. Neurosci. 8, 577-581 (2007).
5. Armbruster, B. N., Li, X., Pausch, M. H., Herlitze, S. & Roth, B. L. Evolving the lock to fit the key to create a family of G protein-coupled receptors potently activated by an inert ligand. Proc. Natl Acad. Sci USA 104, 5163-5168 (2007).
6. Airan, R. D., Thompson, K. R., Fenno, L. E., Bernstein, H. & Deisseroth, K. Temporally precise in vivo control of intracellular signalling. Nature 458, 1025-1029 (2009).
7. Bailes, H. J., Zhuang, L.-Y. & Lucas, R. J. Reproducible and sustained regulation of Gas signalling using a metazoan opsin as an optogenetic tool. PLoS ONE 7, 1-11 (2012).
8. Kim, J.-M. et al. Light-driven activation of b2-adrenergic receptor signaling by a chimeric rhodopsin containing the b2-adrenergic receptor cytoplasmic loopsw. Biochemistry 44, 2284-2292 (2005).
9. Kenakin, T. & Christopoulos, A. Signalling bias in new drug discovery: detection, quantification and therapeutic impact. Nat. Rev. Drug Discov. 12, 205-216 (2013).
10. Luttrell, L. M. & Gesty-Palmer, D. Beyond desensitization: physiological relevance of arrestin-dependent signaling. Pharmacol. Rev. 62, 305-330 (2010).
11. Shenoy, S. K. et al. beta-arrestin-dependent, G protein-independent ERK1/2 activation by the beta2 adrenergic receptor. J. Biol. Chem. 281, 1261-1273 (2006).
12. Bruchas, M. R., Macey, T. A., Lowe, J. D. & Chavkin, C. Kappa Opioid Receptor Activation of p38 MAPK Is GRK3- and Arrestin-dependent in Neurons and Astrocytes. J. Biol. Chem. 281, 18081-18089 (2006).
13. Bruchas, M. R. & Chavkin, C. Kinase cascades and ligand-directed signaling at the kappa opioid receptor. Psychopharmacology (Berl.) 210, 137-147 (2010).
14. Bruchas, M. R. et al. Selective p38a MAPK deletion in serotonergic neurons produces stress resilience in models of depression and addiction. Neuron 71, 498-511 (2011).
15. Wei, H. et al. Independent b-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2. Proc. Natl Acad. Sci USA 100, 10782-10787 (2003).
16. Ren, X.-R. et al. Different G protein-coupled receptor kinases govern G protein and b-arrestin-mediated signaling of V2 vasopressin receptor. Proc. Natl Acad. Sci. USA 102, 1448-1453 (2005).
17. Ahn, S., Shenoy, S. K., Wei, H. & Lefkowitz, R. J. Differential Kinetic and Spatial Patterns of b-Arrestin and G Protein-mediated ERK Activation by the Angiotensin II Receptor. J. Biol. Chem. 279, 35518-35525 (2004).
18. Krasel, C. et al. Dual role of the beta2-adrenergic receptor C terminus for the binding of beta-arrestin and receptor internalization. J. Biol. Chem. 283, 31840-31848 (2008).
19. Hausdorff, W. P. et al. A small region of the beta-adrenergic receptor is selectively involved in its rapid regulation. Proc. Natl Acad. Sci. USA 88, 2979-2983 (1991).
20. Seibold, A., January, B. G., Friedman, J., Hipkin, R. W. & Clark, R. B. Desensitization of b2-adrenergic receptors with mutations of the proposed g protein-coupled receptor kinase phosphorylation sites. J. Biol. Chem. 273, 7637-7642 (1998).
21. Vaughan, D. J. et al. Role of the G protein-coupled receptor kinase site serine cluster in b2-adrenergic receptor internalization, desensitization, and b-arrestin translocation. J. Biol. Chem. 281, 7684-7692 (2006).
22. Hieble, J. P. et al. International Union of Pharmacology. X. Recommendation for nomenclature of alpha 1-adrenoceptors: consensus update. Pharmacol. Rev. 47, 267-270 (1995).
23. Drake, M. T. et al. b-arrestin-biased agonism at the b2-adrenergic receptor. J. Biol. Chem. 283, 5669-5676 (2008).
24. Friedman, J., Babu, B. & Clark, R. B. β2-adrenergic receptor lacking the cyclic amp-dependent protein kinase consensus sites fully activates extracellular signal-regulated kinase 1/2 in human embryonic kidney 293 cells: lack of evidence for Gs/Gi switching. Mol. Pharmacol. 62, 1094-1102 (2002).
25. Schmitt, J. M. & Stork, P. J. S. β2-adrenergic receptor activates extracellular signal-regulated kinases (ERKs) via the small G protein Rap1 and the serine/ threonine kinase B-Raf. J. Biol. Chem. 275, 25342-25350 (2000).
26. Nobles, K. N. et al. Distinct phosphorylation sites on the {beta}2-adrenergic receptor establish a barcode that encodes differential functions of {beta}- arrestin. Sci. Signal. 4, ra51 (2011).
27. Cornwall, M. C., Matthews, H. R., Crouch, R. K. & Fain, G. L. Bleached pigment activates transduction in salamander cones. J. Gen. Physiol. 106, 543-557 (1995).
28. Fain, G. L., Matthews, H. R. & Cornwall, M. C. Dark adaptation in vertebrate photoreceptors. Trends Neurosci. 19, 502-507 (1996).
29. Oh, E., Maejima, T., Liu, C., Deneris, E. & Herlitze, S. Substitution of 5-HT1A receptor signaling by a light-activated G protein-coupled receptor. J. Biol. Chem. 285, 30825-30836 (2010).
30. Cohen, G. B., Yang, T., Robinson, P. R. & Oprian, D. D. Constitutive activation of opsin: Influence of charge at position 134 and size at position 296. Biochemistry 32, 6111-6115 (1993).
31. Pierce, K. L., Premont, R. T. & Lefkowitz, R. J. Seven-transmembrane receptors. Nat. Rev. Mol. Cell Biol. 3, 639-650 (2002).
32. Zastrow, M. von & Kobilka, B. K. Ligand-regulated internalization and recycling of human beta 2-adrenergic receptors between the plasma membrane and endosomes containing transferrin receptors. J. Biol. Chem. 267, 3530-3538 (1992).
33. Zastrow, M. von & Kobilka, B. K. Antagonist-dependent and -independent steps in the mechanism of adrenergic receptor internalization. J. Biol. Chem. 269, 18448-18452 (1994).
34. Morrison, K. J. et al. Repetitive endocytosis and recycling of the beta 2- adrenergic receptor during agonist-induced steady state redistribution. Mol. Pharmacol. 50, 692-699 (1996).
35. Iversen, L. L. Role of Transmitter Uptake Mechanisms in Synaptic Neurotransmission. Br. J. Pharmacol. 41, 571-591 (1971).
36. Pelton, II E. W., Kimelberg, H. K., Shipherd, S. V. & Bourke, R. S. Dopamine and norepinephrine uptake and metabolism by astroglial cells in culture. Life Sci. 28, 1655-1663 (1981).
37. Daigle, T. L., Kearn, C. S. & Mackie, K. Rapid CB1 cannabinoid receptor desensitization defines the time course of ERK1/2 MAP kinase signaling. Neuropharmacology 54, 36-44 (2008).
38. Straiker, A., Wager-Miller, J., Hutchens, J. & Mackie, K. Differential signalling in human cannabinoid CB1 receptors and their splice variants in autaptic hippocampal neurones. Br. J. Pharmacol. 165, 2660-2671 (2012).
39. Sorkin, A. & von Zastrow, M. Endocytosis and signalling: intertwining molecular networks. Nat. Rev. Mol. Cell Biol. 10, 609-622 (2009).
40. Wolff, S. B. E. et al. Amygdala interneuron subtypes control fear learning through disinhibition. Nature 509, 453-458 (2014).
41. Spampanato, J., Polepalli, J. & Sah, P. Interneurons in the basolateral amygdala. Neuropharmacology 60, 765-773 (2011).
42. Ehrlich, I. et al. Amygdala inhibitory circuits and the control of fear memory. Neuron 62, 757-771 (2009).
43. Bailey, K. R. & Crawley, J. N. in Methods of Behavior Analysis in Neuroscience. (ed. Buccafusco, J. J.) (CRC Press, 2009).
44. Silverman, J. L., Yang, M., Lord, C. & Crawley, J. N. Behavioural phenotyping assays for mouse models of autism. Nat. Rev. Neurosci. 11, 490-502 (2010).
45. Crawley, J. & Goodwin, F. K. Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines. Pharmacol. Biochem. Behav. 13, 167-170 (1980).
46. Lepicard, E. M., Joubert, C., Hagneau, I., Perez-Diaz, F. & Chapouthier, G. Differences in anxiety-related behavior and response to diazepam in BALB/ cByJ and C57BL/6J strains of mice. Pharmacol. Biochem. Behav. 67, 739-748 (2000).
47. Kim, T. et al. Injectable, cellular-scale optoelectronics with applications for wireless optogenetics. Science 340, 211-216 (2013).
48. McCall, J. G. et al. Fabrication and application of flexible, multimodal lightemitting devices for wireless optogenetics. Nat. Protoc. 8, 2413-2428 (2013).
49. Tye, K. M. & Deisseroth, K. Optogenetic investigation of neural circuits underlying brain disease in animal models. Nat. Rev. Neurosci. 13, 251-266 (2012).
50. Luttrell, L. M. Minireview: more than just a hammer: ligand 'bias' and pharmaceutical discovery. Mol. Endocrinol. 28, 281-294 (2014).
51. Whalen, E. J., Rajagopal, S. & Lefkowitz, R. J. Therapeutic potential of b-arrestin- and G protein-biased agonists. Trends Mol. Med. 17, 126-139 (2011).
52. Carlsen, J. Immunocytochemical localization of glutamate decarboxylase in the rat basolateral amygdaloid nucleus, with special reference to GABAergic innervation of amygdalostriatal projection neurons. J. Comp. Neurol. 273, 513-526 (1988).
53. Smith, Y. & Pare?, D. Intra-amygdaloid projections of the lateral nucleus in the cat: PHA-L anterograde labeling combined with postembedding GABA and glutamate immunocytochemistry. J. Comp. Neurol. 342, 232-248 (1994).
54. Fenno, L. E. et al. Targeting cells with single vectors using multiple-feature Boolean logic. Nat. Methods 11, 763-772 (2014).
55. Irannejad, R. et al. Conformational biosensors reveal GPCR signalling from endosomes. Nature 495, 534-538 (2013).
56. Tsvetanova, N. G. & von Zastrow, M. Spatial encoding of cyclic AMP signaling specificity by GPCR endocytosis. Nat. Chem. Biol. 10, 1061-1065 (2014).
57. Sparta, D. R. et al. Construction of implantable optical fibers for long-term optogenetic manipulation of neural circuits. Nat. Protoc. 7, 12-23 (2012).
58. Zhang, N. R. et al. Serine 363 is required for nociceptin/orphanin FQ opioid receptor (NOPR) desensitization, internalization, and arrestin signaling. J. Biol. Chem. 287, 42019-42030 (2012).